DGX vs MD · P/E 22, rev $5.94B vs P/E 11, rev $964.0M
Quest Diagnostics Incorporated (DGX) versus Mednax Inc (MD) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Mednax Inc (MD) is a medical care facilities company listed on NYSE.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported MD revenue for 2026-06-30 was $964.0M. Net income was $69.4M. MD currently screens at market cap $1.93B and trailing P/E 11.4.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. MD currently screens at market cap $1.93B and trailing P/E 11.4.
Not investment advice. Open the DGX and MD stock pages for the full models.
Not investment advice.